Health Care & Life Sciences » Biotechnology | Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. | Key People and Executives

Fuad El Hibri
Chairman
Marvin L. White
President, Chief Executive Officer & Director
Daniel J. Abdun-Nabi
Director
John E. Niederhuber
Lead Independent Director
Zsolt Pál Harsányi
Independent Director
Grady Grant
Independent Director
Barbara Lopez Kunz
Independent Director
Fuad El Hibri
Chairman
Marvin L. White
President, Chief Executive Officer & Director
Jeffrey G. Lamothe
CFO, Principal Accounting Officer & Senior VP
Jane Gross
Chief Scientific Officer & Senior Vice President
Scott C. Stromatt
Chief Medical Officer & SVP-Clinical Development
Randy J. Maddux
Chief Manufacturing Officer & Senior VP
Daniel J. Abdun-Nabi
Director
Stacey L. Jurchison
Senior Director-Investor Relations
Shawnte Mitchell
Senior Vice President & General Counsel
John E. Niederhuber
Lead Independent Director
Zsolt Pál Harsányi
Independent Director
Grady Grant
Independent Director
Barbara Lopez Kunz
Independent Director

About Aptevo Therapeutics

View Profile
Address
2401 4th Avenue
Seattle Washington 98121
United States
Employees -
Website http://aptevotherapeutics.com
Updated 07/08/2019
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline includes Otlertuzumab, APVO414, APVO436, ROR1 Candidate, and ALG. APV-527.